Subsequent Magnetic Resonance Imaging (MRI) quantification demonstrated substantially decreased ischemic lesion volume following AAV-GFAP-shRNA-Ptbp1 administration (Figure 6C). Moreover, this intervention attenuated stroke-induced GFAP upregulation in PT mice (Figure 6D). This evidence concerns the gene GFAP and stroke disorder.